The significance of the portal insulin secretion in insulin dependent patients with residual beta-cell function: a safeguard against hormonal and metabolic derangement.
D020155:3-Hydroxybutyric Acid; D000293:Adolescent; D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D006885:Hydroxybutyrates / Q000378:metabolism; D007328:Insulin / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use; D007515:Islets of Langerhans / Q000378:metabolism*; D011168:Portal System / Q000378:metabolism*
D001786:Blood Glucose; D006885:Hydroxybutyrates; D007328:Insulin; D020155:3-Hydroxybutyric Acid